Scientific Reports (Jul 2024)

LINE1-mediated epigenetic repression of androgen receptor transcription causes androgen insensitivity syndrome

  • Jelena Pozojevic,
  • Radhika Sivaprasad,
  • Joshua Laß,
  • Franziska Haarich,
  • Joanne Trinh,
  • Naseebullah Kakar,
  • Kristin Schulz,
  • Kristian Händler,
  • Annemarie A. Verrijn Stuart,
  • Jacques C. Giltay,
  • Koen L. van Gassen,
  • Almuth Caliebe,
  • Paul-Martin Holterhus,
  • Malte Spielmann,
  • Nadine C. Hornig

DOI
https://doi.org/10.1038/s41598-024-65439-w
Journal volume & issue
Vol. 14, no. 1
pp. 1 – 9

Abstract

Read online

Abstract Androgen insensitivity syndrome (AIS) is a difference of sex development (DSD) characterized by different degrees of undervirilization in individuals with a 46,XY karyotype despite normal to high gonadal testosterone production. Classically, AIS is explained by hemizygous mutations in the X-chromosomal androgen receptor (AR) gene. Nevertheless, the majority of individuals with clinically diagnosed AIS do not carry an AR gene mutation. Here, we present a patient with a 46,XY karyotype, born with undervirilized genitalia, age-appropriate testosterone levels and no uterus, characteristic for AIS. Diagnostic whole exome sequencing (WES) showed a maternally inherited LINE1 (L1) retrotransposon insertion in the 5′ untranslated region (5′UTR) of the AR gene. Long-read nanopore sequencing confirmed this as an insertion of a truncated L1 element of ≈ 2.7 kb and showed an increased DNA methylation at the L1 insertion site in patient-derived genital skin fibroblasts (GSFs) compared to healthy controls. The insertion coincided with reduced AR transcript and protein levels in patient-derived GSFs confirming the clinical diagnosis AIS. Our results underline the relevance of retrotransposons in human disease, and expand the growing list of human diseases associated with them.